HK Stock MarketDetailed Quotes

INNOVENT BIO (01801)

Watchlist
  • 89.050
  • -2.050-2.25%
Trading May 8 11:45 CST
154.79BMarket Cap171.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INNOVENT BIO (01801) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical product sales11.9B91.22%
Authorization fee income957.3M7.34%
Income from R & D service charges188.29M1.44%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical product sales11.9B91.22%
Authorization fee income957.3M7.34%
Income from R & D service charges188.29M1.44%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China12.07B92.55%
Europe571.81M4.38%
United States of America.380.61M2.92%
Other19.63M0.15%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 +0.27%
Sample Name
Sample Code
 -0.65%
4
CNOOC
00883
-0.75%
5
PETROCHINA
00857
-1.67%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +63.51%
Sample Name
Sample Code
 +51.73%
Sample Name
Sample Code
 +46.26%
4
Loongson Technology Corporation
688047
+36.26%
5
Business-intelligence Of Oriental Nations Corporation
300166
+31.93%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -